Sickle Cell Disease (SCD) casts a long shadow over India, a country where over 20 million individuals grapple with this genetic blood disorder. India’s efforts to harness the power of stem cell transplants could be a game-changer.
This revolutionary procedure involves the replacement of unhealthy bone marrow with healthy marrow from a donor, possibly curing SCD. However, barriers such as donor scarcity, lack of specialized facilities, and awareness limit the accessibility of this treatment.
DKMS BMST Foundation India is making waves in this area. With over 80,000 registered donors and 90 facilitated transplants, the organization is a testament to the impact of stem cell donation.
Experts across India urge for heightened awareness and collaboration among stakeholders. Dr. Esha Kaul from Max Super Specialty Hospital, Delhi, encapsulates this sentiment, stressing the need for advocacy and collaboration to improve SCD patients’ care.
On World Sickle Cell Day and beyond, let’s focus on empowering individuals and institutions to join forces in elevating stem cell transplants as a viable and accessible treatment option for SCD patients in India.